CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I/II Optimal Dose Study of Lenalidomide in the Non-5q- LOW and INT-1 Risk MDS Patients
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00699842
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:50.801304+00:00
- Published At
- 2014-06-03T00:00:00+00:00
- Record Updated At
- 2025-05-04
- Results Posted At
- 2014-06-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Myelodysplastic Syndrome", "MDS", "Low to Intermediate-1 MDS", "Non-deletion 5q"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-04"- protocolSection.identificationModule.nctId
"NCT00699842"- protocolSection.identificationModule.officialTitle
"A Phase I/II Optimal Dose Study of Lenalidomide in the Non-5q- LOW and INT-1 Risk MDS Patients"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-06-03"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.